SA
GILD icon

Sonoma Allocations’s Gilead Sciences GILD Stock Holding History

Sonoma Allocations’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
3,678
+504
+16% +$66.4K 0.14% 77
2026
Q1 		$439K Sell
3,174
-658
-17% -$92.1K 0.15% 101
2025
Q4 		$543K Buy
+3,832
New +$466K 0.18% 75

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Sonoma Allocations's GILD Position: Q2 2026 in Review

Sonoma Allocations increased its Gilead Sciences (GILD) stake by 16% in Q2 2026, buying an estimated $66.4K and bringing the position to 3,678 shares worth $465K. The position accounts for 0.14% of the portfolio, ranked #77.

Sonoma Allocations first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $543K in Q4 2025. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sonoma Allocations held 3,678 shares of Gilead Sciences worth $465K as of Q2 2026.
  • Sonoma Allocations bought 504 Gilead Sciences shares in Q2 2026, an estimated $66.4K.
  • Gilead Sciences made up 0.14% of Sonoma Allocations's portfolio in Q2 2026, its #77 holding.
  • Sonoma Allocations first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Sonoma Allocations's Gilead Sciences position peaked at $543K in Q4 2025.
  • 911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sonoma Allocations's 13F filing for Q2 2026, filed 8 Jul 2026.